The WHO is in discussions with the Russian institute that developed the Sputnik V candidate vaccine against Covid-19 over its potential application for emergency use listing, the UN agency said. “We look forward to receiving the data for their Sputnik V candidate vaccine. If a product submitted for assessment is found to meet the criteria for listing, WHO will publish the results widely,” WHO said in a statement.